ChatGPT and Medicine: The Good, the Bad, and the Bizarre 

The artificial intelligence chatbot ChatGPT has wowed users with its seemingly human-like ability to generate and respond to language, and worried others by that very same ability. Like virtually every technological innovation that has come before — from the telephone to refrigeration to plastics — ChatGPT is sure to find uses in medicine. People are … Read more

Living Systematic Review Guides Prostate Cancer Treatment Options

As science and clinical medicine advance, oncologists increasingly face the challenge of information overload. It can be hard for oncologists, especially those in community practices who cover many cancers, to keep up with the influx of new therapies, biomarkers, and clinical trial results. The go-to solution has been the systematic review. Researchers team up to … Read more

New Targeted Treatments Emerge For Gastric and Esophageal Cancer 

For years, patients with advanced forms of gastric and esophageal cancer have had relatively few treatment options. Most patients with inoperable tumors would receive chemotherapy, usually a combination of fluorouracil, oxaliplatin and leucovorin (known as FOLFOX). While this regimen is often effective, patients eventually develop resistance to the treatment and their tumors progress. Now, the … Read more

How is Standard of Care for Cancer Treatment Determined? 

In general, standard of care is treatment accepted by medical experts for a certain type of disease and that is widely used by healthcare professionals. It is also called best practice, standard medical care, and standard therapy.  The National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology lay out the recognized standards for cancer … Read more

Living with Metastatic Breast Cancer, Mother is Given a Chance to Raise Her Son 

Just over a year after giving birth to her son, Emmett, Abigail Myers faced a devastating diagnosis of breast cancer in March 2014.   It started when Myers woke up one morning feeling sore. When she found a lump, she rushed to her doctor, all the while in disbelief that she might have cancer.  A resident … Read more

Father with Stage IV Kidney Cancer Enjoys Wedding of a Lifetime

When Chuck Stravin was diagnosed with renal cell carcinoma in 2015, one of his biggest fears was not living long enough to see his four young daughters get married. The disease later metastasized to his lungs as stage IV cancer, but thanks to groundbreaking clinical trials and a care team he considers family, Stravin is … Read more

A Family Navigates Challenges of Rare Blood Cancer Called Waldenström’s Macroglobulinemia

Tom Lomaglio, Jr., learned he had a rare blood cancer called Waldenström’s Macroglobulinemia (WM) in 2000. His father, Tom, Sr., had been diagnosed in 2004, and then his sister, Diane, in 2007. They were all referred to Dana-Farber for care. When Lomaglio visited the first time, he met Steven Treon, MD, PhD, director of the … Read more

HAI Pumps for Advanced Colorectal Cancer: What You Need to Know

Researchers in the late 1970s wanted to address challenges with a chemotherapy drug called floxuridine. It’s a form of chemotherapy invented in the 1950s that turns into its active form, 5-fluorouracil, or 5-FU, when metabolized.   One challenge is that 5-FU has off-target effects, meaning it can damage healthy organs when given throughout the body. In … Read more

Stem Cell Transplant and CAR T-cell Therapy: When Are They Used for Lymphoma and Multiple Myeloma?

For many patients with lymphoma or multiple myeloma, a stem cell transplant with their own stem cells (an autologous transplant) or CAR T-cell therapy can extend life significantly or even cure the disease. A variety of factors influence which of these two treatments is recommended, including:  What is the difference between stem cell transplant and … Read more

Mother with Rare Type of Brain Metastasis Doing Well on Novel Treatment

Langley Perer thought her breast cancer was in the rearview mirror. In 2017, she had received a shocking diagnosis at age 35 of ductal in situ carcinoma (DCIS), the earliest form of breast cancer. “As far as I knew, I had no family history of breast cancer,” she says. DCIS is sometimes referred to as … Read more

Breast Cancer Patient Achieves Her Dreams Thanks to Dana-Farber Care 

When Jennifer Fullerton was diagnosed with breast cancer at age 29, her mind immediately went to the worst-case scenario. “I thought I was going to die. That first day all I could think was ‘why me,’” Fullerton says. “My mom very poignantly told me, ‘Today you can say ‘why me,’ but tomorrow, ‘why not me’. And you … Read more

CNS Lymphoma Patient Grateful For Healthy New Chapter of Family Life

Brian Humberd firmly believes in an attitude of gratitude. The biotech recruiter from Melrose, Massachusetts remains eternally grateful to Dana-Farber medical oncologist David Fisher, MD, who not only recommended a life-saving stem cell transplant to treat his central nervous system (CNS) lymphoma, but whose advice enabled Humberd to become a father after his cancer treatments. … Read more

What is the Difference Between Endometrioid and Non-Endometrioid Uterine Cancer?

Uterine cancer ­­— also known as endometrial cancer — has traditionally been classified as endometrioid or non-endometrioid based on the appearance of the tumor cells under a microscope. Now, as scientists learn more about the molecular makeup of the disease, uterine cancers are increasingly identified by the specific genetic alterations within them. Endometrioid uterine tumors … Read more

Study Shows How PARP Inhibitors Can Be Empowered in Breast Cancer

Logic said that drugs known as PARP inhibitors would work as well ­— and perhaps even better — in breast cancer marked by BRCA gene mutations than in ovarian cancer carrying the same abnormalities. Clinical results said otherwise. Patients with relapsed, BRCA-mutated ovarian cancer survive longer, overall, with PARP inhibitor treatment than any other therapy. … Read more